Propyl gallate reduces the growth of lung cancer cells through caspase‑dependent apoptosis and G1 phase arrest of the cell cycle

Park,Woo Hyun

doi:10.3892/or.2020.7815

Propyl gallate reduces the growth of lung cancer cells through caspase‑dependent apoptosis and G1 phase arrest of the cell cycle

Authors:
- Woo Hyun Park
View Affiliations

Affiliations: Department of Physiology, Medical School, Research Institute for Endocrine Sciences, Jeonbuk National University, Jeonju, Jeollabuk 54907, Republic of Korea
Published online on: October 20, 2020 https://doi.org/10.3892/or.2020.7815
Pages: 2783-2791

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Propyl gallate (3,4,5‑trihydroxybenzoic acid propyl ester; PG) is a synthetic phenolic antioxidant which exerts many effects on tissue and cell functions. In the present study, Calu‑6 and A549 lung cancer cells were used to examine the molecular mechanism of the anti‑growth effects of PG in relation to apoptosis and cell cycle arrest. PG inhibited the growth of both lung cancer cell types in a dose‑dependent manner with an IC50 of 800 µM at 24 h based on MTT assays. DNA flow cytometry showed that PG induced G1 phase arrest of the cell cycle in Calu‑6 and A549 cells. In addition, PG induced apoptosis in both lung cancer cell types, as evidenced by sub‑G1 cell population and Annexin V‑stained cells. Western blot results demonstrated that PG decreased the Bcl‑2 level which was accompanied by an increase in the cleaved form of poly(ADP‑ribose) polymerase (PARP). PG also triggered loss of mitochondrial membrane potential (MMP; ∆Ψm) and decreased MMP (∆Ψm) levels in both lung cancer cell types, as assessed by FACS analysis. Furthermore, PG upregulated the activities of caspase‑3 and caspase‑8 in Calu‑6 cells. In conclusion, PG treatment inhibited the growth of lung cancer cells, especially Calu‑6 cells via caspase‑dependent apoptosis as well as G1 phase arrest of the cell cycle.

View Figures

View References

1	Final report on the amended safety assessment of propyl gallate. Int J Toxicol. 26 (Suppl 3):89–118. 2007. View Article : Google Scholar : PubMed/NCBI
2	Wu TW, Fung KP, Zeng LH, Wu J and Nakamura H: Propyl gallate as a hepatoprotector in vitro and in vivo. Biochem Pharmacol. 48:419–422. 1994. View Article : Google Scholar : PubMed/NCBI
3	Reddan JR, Giblin FJ, Sevilla M, Padgaonkar V, Dziedzic DC, Leverenz VR, Misra IC, Chang JS and Pena JT: Propyl gallate is a superoxide dismutase mimic and protects cultured lens epithelial cells from H2O2 insult. Exp Eye Res. 76:49–59. 2003. View Article : Google Scholar : PubMed/NCBI
4	Chen CH, Liu TZ, Chen CH, Wong CH, Chen CH, Lu FJ and Chen SC: The efficacy of protective effects of tannic acid, gallic acid, ellagic acid, and propyl gallate against hydrogen peroxide-induced oxidative stress and DNA damages in IMR-90 cells. Mol Nutr Food Res. 51:962–968. 2007. View Article : Google Scholar : PubMed/NCBI
5	Hirose M, Yada H, Hakoi K, Takahashi S and Ito N: Modification of carcinogenesis by alpha-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model. Carcinogenesis. 14:2359–2364. 1993. View Article : Google Scholar : PubMed/NCBI
6	Kobayashi H, Oikawa S, Hirakawa K and Kawanishi S: Metal-mediated oxidative damage to cellular and isolated DNA by gallic acid, a metabolite of antioxidant propyl gallate. Mutat Res. 558:111–120. 2004. View Article : Google Scholar : PubMed/NCBI
7	Kawanishi S, Oikawa S and Murata M: Evaluation for safety of antioxidant chemopreventive agents. Antioxid Redox Signal. 7:1728–1739. 2005. View Article : Google Scholar : PubMed/NCBI
8	Nakagawa Y and Tayama S: Cytotoxicity of propyl gallate and related compounds in rat hepatocytes. Arch Toxicol. 69:204–208. 1995. View Article : Google Scholar : PubMed/NCBI
9	Ham J, Lim W, Park S, Bae H, You S and Song G: Synthetic phenolic antioxidant propyl gallate induces male infertility through disruption of calcium homeostasis and mitochondrial function. Environ Pollut. 248:845–856. 2019. View Article : Google Scholar : PubMed/NCBI
10	Han YH, Moon HJ, You BR and Park WH: Propyl gallate inhibits the growth of calf pulmonary arterial endothelial cells via glutathione depletion. Toxicol In Vitro. 24:1183–1189. 2010. View Article : Google Scholar : PubMed/NCBI
11	Boyd I and Beveridge EG: Relationship between the antibacterial activity towards escherichia coli NCTC 5933 and the physico-chemical properties of some esters of 3,4,5-trihydroxybenzoic acid (Gallic acid). Microbios. 24:173–184. 1979.PubMed/NCBI
12	Martinez-Alonso D and Malumbres M: Mammalian cell cycle cyclins. Semin Cell Dev Biol. 2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
13	Dalton S: Linking the cell cycle to cell fate decisions. Trends Cell Biol. 25:592–600. 2015. View Article : Google Scholar : PubMed/NCBI
14	Huska JD, Lamb HM and Hardwick JM: Overview of BCL-2 family proteins and therapeutic potentials. Methods Mol Biol. 1877:1–21. 2019. View Article : Google Scholar : PubMed/NCBI
15	Chung C: Restoring the switch for cancer cell death: Targeting the apoptosis signaling pathway. Am J Health Syst Pharm. 75:945–952. 2018. View Article : Google Scholar : PubMed/NCBI
16	Liu X, Yue P, Zhou Z, Khuri FR and Sun SY: Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst. 96:1769–1780. 2004. View Article : Google Scholar : PubMed/NCBI
17	Wurstle ML, Laussmann MA and Rehm M: The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp Cell Res. 318:1213–1220. 2012. View Article : Google Scholar : PubMed/NCBI
18	Hu Z, Li M, Chen Z, Zhan C, Lin Z and Wang Q: Advances in clinical trials of targeted therapy and immunotherapy of lung cancer in 2018. Transl Lung Cancer Res. 8:1091–1106. 2019. View Article : Google Scholar : PubMed/NCBI
19	Carter BW, Lichtenberger JP III, Benveniste MK, de Groot PM, Wu CC, Erasmus JJ and Truong MT: Revisions to the TNM staging of lung cancer: Rationale, significance, and clinical application. Radiographics. 38:374–391. 2018. View Article : Google Scholar : PubMed/NCBI
20	Han YH, Moon HJ, You BR, Yang YM, Kim SZ, Kim SH and Park WH: Propyl gallate inhibits the growth of endothelial cells, especially calf pulmonary arterial endothelial cells via caspase-independent apoptosis. Int J Mol Med. 25:937–944. 2010.PubMed/NCBI
21	Chen CH, Lin WC, Kuo CN and Lu FJ: Role of redox signaling regulation in propyl gallate-induced apoptosis of human leukemia cells. Food Chem Toxicol. 49:494–501. 2011. View Article : Google Scholar : PubMed/NCBI
22	Wei PL, Huang CY and Chang YJ: Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy. PLoS One. 14:e02105132019. View Article : Google Scholar : PubMed/NCBI
23	Han YH and Park WH: Propyl gallate inhibits the growth of HeLa cells via regulating intracellular GSH level. Food Chem Toxicol. 47:2531–2538. 2009. View Article : Google Scholar : PubMed/NCBI
24	Han YH, Moon HJ, You BR and Park WH: The anti-apoptotic effects of caspase inhibitors on propyl gallate-treated HeLa cells in relation to reactive oxygen species and glutathione levels. Arch Toxicol. 83:825–833. 2009. View Article : Google Scholar : PubMed/NCBI
25	Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 15:269–290. 1999. View Article : Google Scholar : PubMed/NCBI
26	Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:346–347. 1994. View Article : Google Scholar : PubMed/NCBI
27	Daniel JW: Metabolic aspects of antioxidants and preservatives. Xenobiotica. 16:1073–1078. 1986. View Article : Google Scholar : PubMed/NCBI
28	Dacre JC: Long-term toxicity study of n-propyl gallate in mice. Food Cosmet Toxicol. 12:125–129. 1974. View Article : Google Scholar : PubMed/NCBI
29	Rosin MP and Stich HF: Enhancing and inhibiting effects of propyl gallate on carcinogen-induced mutagenesis. J Environ Pathol Toxicol. 4:159–167. 1980.PubMed/NCBI
30	Abdo KM, Huff JE, Haseman JK and Alden CJ: No evidence of carcinogenicity of D-mannitol and propyl gallate in F344 rats or B6C3F1 mice. Food Chem Toxicol. 24:1091–1097. 1986. View Article : Google Scholar : PubMed/NCBI
31	Park WH: Effects of antioxidants and MAPK inhibitors on cell death and reactive oxygen species levels in H2O2-treated human pulmonary fibroblasts. Oncol Lett. 5:1633–1638. 2013. View Article : Google Scholar : PubMed/NCBI
32	Nakagawa Y, Nakajima K, Tayama S and Moldeus P: Metabolism and cytotoxicity of propyl gallate in isolated rat hepatocytes: effects of a thiol reductant and an esterase inhibitor. Mol Pharmacol. 47:1021–1027. 1995.PubMed/NCBI
33	Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
34	Ashkenazi A and Dixit VM: Death receptors: Signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI